Mark Rus is the founder of Delix Therapeutics. Delix Therapeutics has raised $100M in total funding. Latest round: Series A. Backed by Comerica Bank.
Mark Rus is the President & Chief Executive Officer of Delix Therapeutics, a neuroscience company focused on developing novel disease-modifying therapeutics for psychiatric and neurological conditions. Before Delix, Rus was an Entrepreneur-in-Residence and Venture Advisor at Atlas Venture. He also held several senior roles at Shire for over 13 years, where he helped build a $2.5 billion neuroscience business.
Full founder directory · Investor directory · Company funding database · Fundraising library